Sarah Gordon-Wild
Director/Board Member bij Leweston School
Vermogen: 463 747 $ op 31-03-2024
Profiel
Sarah Gordon-Wild is currently a Non-Executive Director at Evox Therapeutics Ltd., a Director at Larkham Ltd., a Director at Sgw Research Ltd., a Director at The Bridport Literary Festival Ltd., a Partner at Hy.
Duke & Son Ltd., and a Member-Governors Board at Leweston School.
Previously, she served as a Non-Executive Director at Oxford Nanopore Technologies Plc from 2015 to 2023, a Managing Director at Lone Pine Capital (UK) Ltd.
from 1998 to 2003, and an Independent Non-Executive Director at Redx Pharma Plc from 2020 to 2023.
Ms. Gordon-Wild graduated from Imperial College London and the University of Aberdeen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REDX PHARMA PLC
0.34% | 30-09-2023 | 1 316 587 ( 0.34% ) | 307 686 $ | 31-03-2024 |
| 31-12-2022 | 101 678 ( 0.01% ) | 156 060 $ | 31-03-2024 |
Actieve functies van Sarah Gordon-Wild
| Bedrijven | Functie | Begin |
|---|---|---|
Hy. Duke & Son Ltd.
 Hy. Duke & Son Ltd. Specialty StoresRetail Trade Hy. The private company is based in Dorchester, UK, and their fine art salerooms are centrally located in the county town, close to the main Dorchester South railway station. Duke & Son Ltd. is a British company that deals with militaria and sporting goods, as well as silver and objects of vertu. The company also provides valuations for inheritance tax assessment. The company was founded in 1999, and Lee Young has been the CEO of the company since 2017. | Corporate Officer/Principal | - |
| Leweston School | Director/Board Member | - |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
| Larkham Ltd. | Director/Board Member | - |
| Sgw Research Ltd. | Director/Board Member | - |
| The Bridport Literary Festival Ltd. | Director/Board Member | - |
Eerdere bekende functies van Sarah Gordon-Wild
| Bedrijven | Functie | Einde |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Director/Board Member | 19-12-2023 |
| REDX PHARMA PLC | Director/Board Member | 30-09-2023 |
Lone Pine Capital (UK) Ltd.
 Lone Pine Capital (UK) Ltd. Investment ManagersFinance Lone Pine Capital UK Ltd. (Lone Pine-UK) is the Great Britain-based alternative investment subsidiary of Lone Pine Capital LLC in the US. Headquartered in London, Lone Pine-UK was founded in 2002 and provides investment management services to pooled investment vehicles as well as pension and profit-sharing plans. | Chief Executive Officer | 01-01-2003 |
Opleiding van Sarah Gordon-Wild
| Imperial College London | Graduate Degree |
| University of Aberdeen | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| REDX PHARMA PLC | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Lone Pine Capital (UK) Ltd.
Lone Pine Capital (UK) Ltd. Investment ManagersFinance Lone Pine Capital UK Ltd. (Lone Pine-UK) is the Great Britain-based alternative investment subsidiary of Lone Pine Capital LLC in the US. Headquartered in London, Lone Pine-UK was founded in 2002 and provides investment management services to pooled investment vehicles as well as pension and profit-sharing plans. | Finance |
Hy. Duke & Son Ltd.
Hy. Duke & Son Ltd. Specialty StoresRetail Trade Hy. The private company is based in Dorchester, UK, and their fine art salerooms are centrally located in the county town, close to the main Dorchester South railway station. Duke & Son Ltd. is a British company that deals with militaria and sporting goods, as well as silver and objects of vertu. The company also provides valuations for inheritance tax assessment. The company was founded in 1999, and Lee Young has been the CEO of the company since 2017. | Retail Trade |
| Leweston School | |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Health Technology |
| Larkham Ltd. | |
| Sgw Research Ltd. | |
| The Bridport Literary Festival Ltd. |
